Trials / Withdrawn
WithdrawnNCT01841814
Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy
Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy: Prospective Longitudinal Study Over 12 Months.
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess changes of bone mineral density (BMD) at 12 months during the therapeutic management of patients with lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Bone densitometry. |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-04-29
- Last updated
- 2016-12-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01841814. Inclusion in this directory is not an endorsement.